Marker Therapeutics, Inc. MRKR
0.85 USD +0.02 (+1.98%)
Regular-session close
0.85 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
0.8347 Day range 0.92
0.81 52-week range 2.46
- YTD
- -42.74%
- 1 year
- -15.52%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers InflaRx (NASDAQ:IFRX) stock rose 12.7% to $1.32 during Friday's after-market session. The market value of their outstanding shares is at $182.6 million. Instinct Bio Technical Co…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 13.2% to $1.29 during Wednesday's pre-market session. The company's market cap stands at $5.4 million. The company's, Q2 earnings came…benzinga.com Marker Therapeutics Secures $2.6M From FDA Through Its Orphan Products Clinical Trials Grants Program To Support Phase 1 Clinical Study Evaluating Lead Investigational MAR-T Cell Therapy, MT-601, In Pancreatic Cancer Marker Therapeutics, Inc. (NASDAQ:MRKR), is a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies under an exclusive worldwide license from Baylor…
